1-(1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-cyclohexyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-cyclohexyl-1-(1-methylbenzimidazol-2-yl)methanimine;N-[(2,4-dimethylphenyl)methyl]-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(3-methylbutan-2-yl)methanimine;N-hexyl-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine;N-(3-methylbutan-2-yl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine

C190H196F3N27 — CID 158125765

IUPAC1-(1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-cyclohexyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-cyclohexyl-1-(1-methylbenzimidazol-2-yl)methanimine;N-[(2,4-dimethylphenyl)methyl]-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(3-methylbutan-2-yl)methanimine;N-hexyl-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine;N-(3-methylbutan-2-yl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine
SMILESC(=N/C1CCCCC1)\c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2[nH]1.CC(C)C(C)/N=C/c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2[nH]1.CC(C)C(C)/N=C/c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2n1C.CC(C)C/N=C/c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2n1C.CC(C)C/N=C/c1nc2ccccc2n1C.CCCCCC/N=C/c1nc2ccccc2n1C.Cc1ccc(C/N=C/c2nc3c(-c4ccccc4)ccc(-c4ccccc4)c3[nH]2)c(C)c1.Cn1c(/C=N/C2CCCCC2)nc2ccccc21.FC(F)(F)c1ccccc1C/N=C/c1nc2ccccc2[nH]1
InChIInChI=1S/C29H25N3.C26H25N3.C26H27N3.2C25H25N3.C16H12F3N3.C15H19N3.C15H21N3.C13H17N3/c1-20-13-14-24(21(2)17-20)18-30-19-27-31-28-25(22-9-5-3-6-10-22)15-16-26(29(28)32-27)23-11-7-4-8-12-23;1-4-10-19(11-5-1)22-16-17-23(20-12-6-2-7-13-20)26-25(22)28-24(29-26)18-27-21-14-8-3-9-15-21;1-18(2)19(3)27-17-24-28-25-22(20-11-7-5-8-12-20)15-16-23(26(25)29(24)4)21-13-9-6-10-14-21;1-18(2)16-26-17-23-27-24-21(19-10-6-4-7-11-19)14-15-22(25(24)28(23)3)20-12-8-5-9-13-20;1-17(2)18(3)26-16-23-27-24-21(19-10-6-4-7-11-19)14-15-22(25(24)28-23)20-12-8-5-9-13-20;17-16(18,19)12-6-2-1-5-11(12)9-20-10-15-21-13-7-3-4-8-14(13)22-15;1-18-14-10-6-5-9-13(14)17-15(18)11-16-12-7-3-2-4-8-12;1-3-4-5-8-11-16-12-15-17-13-9-6-7-10-14(13)18(15)2;1-10(2)8-14-9-13-15-11-6-4-5-7-12(11)16(13)3/h3-17,19H,18H2,1-2H3,(H,31,32);1-2,4-7,10-13,16-18,21H,3,8-9,14-15H2,(H,28,29);5-19H,1-4H3;4-15,17-18H,16H2,1-3H3;4-18H,1-3H3,(H,27,28);1-8,10H,9H2,(H,21,22);5-6,9-12H,2-4,7-8H2,1H3;6-7,9-10,12H,3-5,8,11H2,1-2H3;4-7,9-10H,8H2,1-3H3/b30-19+;27-18+;27-17+;26-17+;26-16+;20-10+;16-11+;16-12+;14-9+
InChIKeyFSDNZTZDNVRBNI-TWQPENBLSA-N
MW2914.84 g/mol
LogP46.24
Rot. Bonds38

About 1-(1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-cyclohexyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-cyclohexyl-1-(1-methylbenzimidazol-2-yl)methanimine;N-[(2,4-dimethylphenyl)methyl]-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(3-methylbutan-2-yl)methanimine;N-hexyl-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine;N-(3-methylbutan-2-yl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine

1-(1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-cyclohexyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-cyclohexyl-1-(1-methylbenzimidazol-2-yl)methanimine;N-[(2,4-dimethylphenyl)methyl]-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(3-methylbutan-2-yl)methanimine;N-hexyl-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine;N-(3-methylbutan-2-yl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine (PubChem CID 158125765) has the molecular formula C190H196F3N27 and a molecular weight of 2914.84 g/mol. Its IUPAC name is 1-(1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-cyclohexyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-cyclohexyl-1-(1-methylbenzimidazol-2-yl)methanimine;N-[(2,4-dimethylphenyl)methyl]-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(3-methylbutan-2-yl)methanimine;N-hexyl-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine;N-(3-methylbutan-2-yl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine.

Molecular Properties

Compound Name1-(1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-cyclohexyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-cyclohexyl-1-(1-methylbenzimidazol-2-yl)methanimine;N-[(2,4-dimethylphenyl)methyl]-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(3-methylbutan-2-yl)methanimine;N-hexyl-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine;N-(3-methylbutan-2-yl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine
PubChem CID158125765
Molecular FormulaC190H196F3N27
Molecular Weight2914.84 g/mol
Exact Mass2912.61
IUPAC Name1-(1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-cyclohexyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-cyclohexyl-1-(1-methylbenzimidazol-2-yl)methanimine;N-[(2,4-dimethylphenyl)methyl]-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(3-methylbutan-2-yl)methanimine;N-hexyl-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine;N-(3-methylbutan-2-yl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine
SMILESC(=N/C1CCCCC1)\c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2[nH]1.CC(C)C(C)/N=C/c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2[nH]1.CC(C)C(C)/N=C/c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2n1C.CC(C)C/N=C/c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2n1C.CC(C)C/N=C/c1nc2ccccc2n1C.CCCCCC/N=C/c1nc2ccccc2n1C.Cc1ccc(C/N=C/c2nc3c(-c4ccccc4)ccc(-c4ccccc4)c3[nH]2)c(C)c1.Cn1c(/C=N/C2CCCCC2)nc2ccccc21.FC(F)(F)c1ccccc1C/N=C/c1nc2ccccc2[nH]1
InChIInChI=1S/C29H25N3.C26H25N3.C26H27N3.2C25H25N3.C16H12F3N3.C15H19N3.C15H21N3.C13H17N3/c1-20-13-14-24(21(2)17-20)18-30-19-27-31-28-25(22-9-5-3-6-10-22)15-16-26(29(28)32-27)23-11-7-4-8-12-23;1-4-10-19(11-5-1)22-16-17-23(20-12-6-2-7-13-20)26-25(22)28-24(29-26)18-27-21-14-8-3-9-15-21;1-18(2)19(3)27-17-24-28-25-22(20-11-7-5-8-12-20)15-16-23(26(25)29(24)4)21-13-9-6-10-14-21;1-18(2)16-26-17-23-27-24-21(19-10-6-4-7-11-19)14-15-22(25(24)28(23)3)20-12-8-5-9-13-20;1-17(2)18(3)26-16-23-27-24-21(19-10-6-4-7-11-19)14-15-22(25(24)28-23)20-12-8-5-9-13-20;17-16(18,19)12-6-2-1-5-11(12)9-20-10-15-21-13-7-3-4-8-14(13)22-15;1-18-14-10-6-5-9-13(14)17-15(18)11-16-12-7-3-2-4-8-12;1-3-4-5-8-11-16-12-15-17-13-9-6-7-10-14(13)18(15)2;1-10(2)8-14-9-13-15-11-6-4-5-7-12(11)16(13)3/h3-17,19H,18H2,1-2H3,(H,31,32);1-2,4-7,10-13,16-18,21H,3,8-9,14-15H2,(H,28,29);5-19H,1-4H3;4-15,17-18H,16H2,1-3H3;4-18H,1-3H3,(H,27,28);1-8,10H,9H2,(H,21,22);5-6,9-12H,2-4,7-8H2,1H3;6-7,9-10,12H,3-5,8,11H2,1-2H3;4-7,9-10H,8H2,1-3H3/b30-19+;27-18+;27-17+;26-17+;26-16+;20-10+;16-11+;16-12+;14-9+
InChIKeyFSDNZTZDNVRBNI-TWQPENBLSA-N
XLogP46.24
TPSA315.06 Ų
H-Bond Donors4
H-Bond Acceptors23
Rotatable Bonds38
Heavy Atoms220
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002914.84
LogP ≤ 546.24
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze 1-(1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-cyclohexyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-cyclohexyl-1-(1-methylbenzimidazol-2-yl)methanimine;N-[(2,4-dimethylphenyl)methyl]-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(3-methylbutan-2-yl)methanimine;N-hexyl-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine;N-(3-methylbutan-2-yl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

1-[[4-[2-(4,5-dihydro-1H-imidazol-2-yl)phenyl]phenyl]methyl]-4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazole
CID 25147556
1-[[4-[2-(5-chloro-1H-imidazol-2-yl)phenyl]phenyl]methyl]-4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazole
CID 44563175
2-(1H-benzimidazol-5-yl)-5-(5-naphthalen-2-yl-1H-benzimidazol-2-yl)-1H-benzimidazole
CID 135430779
3,6-bis[5-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-benzimidazol-2-yl]-9-[4-(4-methylpiperazin-1-yl)butyl]carbazole
CID 137100819
N,N,N',N'-tetrakis[(6-methyl-1H-benzimidazol-2-yl)methyl]ethane-1,2-diamine
CID 335974
US11649237, Example 213
CID 137525071
US11649237, Example 209
CID 137525203
US11649237, Example 215
CID 137525288
US11649237, Example 216
CID 137527786
US11649237, Example 212
CID 137527994
US11649237, Example 214
CID 137528026
1-[[4-[2-(1H-imidazol-2-yl)phenyl]phenyl]methyl]-4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazole
CID 44563174

Frequently Asked Questions

What is the IUPAC name of 1-(1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-cyclohexyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-cyclohexyl-1-(1-methylbenzimidazol-2-yl)methanimine;N-[(2,4-dimethylphenyl)methyl]-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(3-methylbutan-2-yl)methanimine;N-hexyl-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine;N-(3-methylbutan-2-yl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine?
The IUPAC name of 1-(1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-cyclohexyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-cyclohexyl-1-(1-methylbenzimidazol-2-yl)methanimine;N-[(2,4-dimethylphenyl)methyl]-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(3-methylbutan-2-yl)methanimine;N-hexyl-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine;N-(3-methylbutan-2-yl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine (CID 158125765) is 1-(1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-cyclohexyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-cyclohexyl-1-(1-methylbenzimidazol-2-yl)methanimine;N-[(2,4-dimethylphenyl)methyl]-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(3-methylbutan-2-yl)methanimine;N-hexyl-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine;N-(3-methylbutan-2-yl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine.
What is the SMILES notation for 1-(1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-cyclohexyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-cyclohexyl-1-(1-methylbenzimidazol-2-yl)methanimine;N-[(2,4-dimethylphenyl)methyl]-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(3-methylbutan-2-yl)methanimine;N-hexyl-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine;N-(3-methylbutan-2-yl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine?
The canonical SMILES for 1-(1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-cyclohexyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-cyclohexyl-1-(1-methylbenzimidazol-2-yl)methanimine;N-[(2,4-dimethylphenyl)methyl]-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(3-methylbutan-2-yl)methanimine;N-hexyl-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine;N-(3-methylbutan-2-yl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine is C(=N/C1CCCCC1)\c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2[nH]1.CC(C)C(C)/N=C/c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2[nH]1.CC(C)C(C)/N=C/c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2n1C.CC(C)C/N=C/c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2n1C.CC(C)C/N=C/c1nc2ccccc2n1C.CCCCCC/N=C/c1nc2ccccc2n1C.Cc1ccc(C/N=C/c2nc3c(-c4ccccc4)ccc(-c4ccccc4)c3[nH]2)c(C)c1.Cn1c(/C=N/C2CCCCC2)nc2ccccc21.FC(F)(F)c1ccccc1C/N=C/c1nc2ccccc2[nH]1.
What is the InChIKey of 1-(1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-cyclohexyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-cyclohexyl-1-(1-methylbenzimidazol-2-yl)methanimine;N-[(2,4-dimethylphenyl)methyl]-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(3-methylbutan-2-yl)methanimine;N-hexyl-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine;N-(3-methylbutan-2-yl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine?
The InChIKey is FSDNZTZDNVRBNI-TWQPENBLSA-N. The full InChI is InChI=1S/C29H25N3.C26H25N3.C26H27N3.2C25H25N3.C16H12F3N3.C15H19N3.C15H21N3.C13H17N3/c1-20-13-14-24(21(2)17-20)18-30-19-27-31-28-25(22-9-5-3-6-10-22)15-16-26(29(28)32-27)23-11-7-4-8-12-23;1-4-10-19(11-5-1)22-16-17-23(20-12-6-2-7-13-20)26-25(22)28-24(29-26)18-27-21-14-8-3-9-15-21;1-18(2)19(3)27-17-24-28-25-22(20-11-7-5-8-12-20)15-16-23(26(25)29(24)4)21-13-9-6-10-14-21;1-18(2)16-26-17-23-27-24-21(19-10-6-4-7-11-19)14-15-22(25(24)28(23)3)20-12-8-5-9-13-20;1-17(2)18(3)26-16-23-27-24-21(19-10-6-4-7-11-19)14-15-22(25(24)28-23)20-12-8-5-9-13-20;17-16(18,19)12-6-2-1-5-11(12)9-20-10-15-21-13-7-3-4-8-14(13)22-15;1-18-14-10-6-5-9-13(14)17-15(18)11-16-12-7-3-2-4-8-12;1-3-4-5-8-11-16-12-15-17-13-9-6-7-10-14(13)18(15)2;1-10(2)8-14-9-13-15-11-6-4-5-7-12(11)16(13)3/h3-17,19H,18H2,1-2H3,(H,31,32);1-2,4-7,10-13,16-18,21H,3,8-9,14-15H2,(H,28,29);5-19H,1-4H3;4-15,17-18H,16H2,1-3H3;4-18H,1-3H3,(H,27,28);1-8,10H,9H2,(H,21,22);5-6,9-12H,2-4,7-8H2,1H3;6-7,9-10,12H,3-5,8,11H2,1-2H3;4-7,9-10H,8H2,1-3H3/b30-19+;27-18+;27-17+;26-17+;26-16+;20-10+;16-11+;16-12+;14-9+.
What are the key properties of 1-(1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-cyclohexyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-cyclohexyl-1-(1-methylbenzimidazol-2-yl)methanimine;N-[(2,4-dimethylphenyl)methyl]-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(3-methylbutan-2-yl)methanimine;N-hexyl-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine;N-(3-methylbutan-2-yl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine?
1-(1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-cyclohexyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-cyclohexyl-1-(1-methylbenzimidazol-2-yl)methanimine;N-[(2,4-dimethylphenyl)methyl]-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(3-methylbutan-2-yl)methanimine;N-hexyl-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine;N-(3-methylbutan-2-yl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine has a molecular weight of 2914.84 g/mol, XLogP of 46.24, 38 rotatable bonds, 4 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-cyclohexyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;N-cyclohexyl-1-(1-methylbenzimidazol-2-yl)methanimine;N-[(2,4-dimethylphenyl)methyl]-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(3-methylbutan-2-yl)methanimine;N-hexyl-1-(1-methylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine;N-(3-methylbutan-2-yl)-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2-methylpropyl)methanimine is sourced from PubChem (CID 158125765), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).